Oramed Pharmaceuticals Shares Are Trading Higher After the Company Announced a $20 Million Buyback Program and Finalized Its Joint Venture With Hefei Tianhui Biotech.
Oramed Pharmaceuticals Shares Are Trading Higher After the Company Announced a $20 Million Buyback Program and Finalized Its Joint Venture With Hefei Tianhui Biotech.
Oramed pharmaceuticals宣佈推出2千萬美元的股票回購計劃並與合肥天輝生物技術公司完成了合資企業。其股票交易價格上漲。
Oramed Pharmaceuticals Shares Are Trading Higher After the Company Announced a $20 Million Buyback Program and Finalized Its Joint Venture With Hefei Tianhui Biotech.
Oramed pharmaceuticals宣佈推出2千萬美元的股票回購計劃並與合肥天輝生物技術公司完成了合資企業。其股票交易價格上漲。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。